Want to see HK:0474 full AI Analyst Report?
Total Valuation
Aceso Life Science Group Limited has a market cap or net worth of HK$1.26B. The enterprise value is HK$1.89K.
Market CapHK$1.26B
Enterprise ValueHK$1.89K
Share Statistics
Aceso Life Science Group Limited has 8,858,127,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,858,127,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aceso Life Science Group Limited’s return on equity (ROE) is 0.74 and return on invested capital (ROIC) is 2.23%.
Return on Equity (ROE)0.74
Return on Assets (ROA)0.19
Return on Invested Capital (ROIC)2.23%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee2.29M
Profits Per Employee12.07M
Employee Count28
Asset Turnover0.04
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Aceso Life Science Group Limited is 3.0. Aceso Life Science Group Limited’s PEG ratio is 0.04.
PE Ratio3.0
PS Ratio10.91
PB Ratio1.53
Price to Fair Value1.53
Price to FCF34.90
Price to Operating Cash Flow-15.98
PEG Ratio0.04
Income Statement
In the last 12 months, Aceso Life Science Group Limited had revenue of 64.00M and earned 338.00M in profits. Earnings per share was -0.06.
Revenue64.00M
Gross Profit54.00M
Operating Income40.00M
Pretax Income-421.00M
Net Income338.00M
EBITDA-297.00M
Earnings Per Share (EPS)-0.06
Cash Flow
In the last 12 months, operating cash flow was -79.00M and capital expenditures 0.00, giving a free cash flow of -79.00M billion.
Operating Cash Flow-79.00M
Free Cash Flow-79.00M
Free Cash Flow per Share>-0.01
Dividends & Yields
Aceso Life Science Group Limited pays an annual dividend of HK$0.06, resulting in a dividend yield of 1.2%
Dividend Per ShareHK$0.06
Dividend Yield1.2%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.11
52-Week Price Change184.00%
50-Day Moving Average0.13
200-Day Moving Average0.12
Relative Strength Index (RSI)44.33
Average Volume (3m)5.34M
Important Dates
Aceso Life Science Group Limited upcoming earnings date is Dec 1, 2026, TBA (Confirmed).
Last Earnings DateJun 26, 2026
Next Earnings DateDec 1, 2026
Ex-Dividend Date―
Financial Position
Aceso Life Science Group Limited as a current ratio of 5.52, with Debt / Equity ratio of 259.74%
Current Ratio5.52
Quick Ratio5.52
Debt to Market Cap1.70
Net Debt to EBITDA-3.51
Interest Coverage Ratio0.35
Taxes
In the past 12 months, Aceso Life Science Group Limited has paid 8.00M in taxes.
Income Tax8.00M
Effective Tax Rate-0.02
Enterprise Valuation
Aceso Life Science Group Limited EV to EBITDA ratio is -5.86, with an EV/FCF ratio of 87.00.
EV to Sales27.19
EV to EBITDA-5.86
EV to Free Cash Flow87.00
EV to Operating Cash Flow87.00
Balance Sheet
Aceso Life Science Group Limited has HK$345.00M in cash and marketable securities with HK$1.19B in debt, giving a net cash position of -HK$842.00M billion.
Cash & Marketable SecuritiesHK$345.00M
Total DebtHK$1.19B
Net Cash-HK$842.00M
Net Cash Per Share-HK$0.10
Tangible Book Value Per ShareHK$0.08
Margins
Gross margin is 100.00%, with operating margin of 62.50%, and net profit margin of 528.13%.
Gross Margin100.00%
Operating Margin62.50%
Pretax Margin-657.81%
Net Profit Margin528.13%
EBITDA Margin-464.06%
EBIT Margin-479.69%
Analyst Forecast
The average price target for Aceso Life Science Group Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-57.48%
EPS Growth Forecast―